ArticleAsian journal of transfusion science
Higher prevalence of anti-S and anti-M in South India: A single-center cross-sectional analytical study.
Article in Asian journal of transfusion science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlloimmunization, a dreadful complication of blood transfusion, varies between populations and geographical regions. The antibody prevalence of the South Indian population was studied as the data were scarce. Rh-Kell matching is traditionally followed, but other alloantibodies may have higher prevalence because of geographical variation. MATERIALS AND
methodsIt is a retrospective study on alloantibody prevalence in a tertiary care hospital in southern India from April 2021 to March 2023. The frequency, prevalence, and proportion of them are studied.
resultsOut of 6640 patients, 1128 (16.98%) were Rh D negative. One hundred and thirty-three patients have 155 alloantibodies, among which anti-D is the most common (1.02%), followed by anti-C (0.21%) and S (0.19%), with none having anti-Kell alloantibodies. Here, 1.58% of alloantibodies are formed against Rh and Kell blood group system, whereas 1.94% are against Rh MNS and system.
conclusionAnti-M and anti-S are common alloantibodies prevalent in the southern India population besides Rh. The focus should be given to Rh-MNS-matched blood in our population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.